XIMLUCI

This brand name is authorized in Austria, Cyprus, Estonia, Spain, Finland, France, Ireland, Italy, Lithuania, Poland, Romania, United Kingdom

Active ingredients

The drug XIMLUCI contains one active pharmaceutical ingredient (API):

1 Ranibizumab
UNII ZL1R02VT79 - RANIBIZUMAB

Ranibizumab is a humanised recombinant monoclonal antibody fragment targeted against human vascular endothelial growth factor A (VEGF-A). It binds with high affinity to the VEGF-A isoforms, thereby preventing binding of VEGF-A to its receptors VEGFR-1 and VEGFR-2. Binding of VEGF-A to its receptors leads to endothelial cell proliferation and neovascularisation, as well as vascular leakage, all of which are thought to contribute to the progression of the neovascular form of age-related macular degeneration, pathologic myopia and CNV or to visual impairment caused by either diabetic macular oedema or macular oedema secondary to RVO in adults and retinopathy of prematurity in preterm infants.

Read about Ranibizumab

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
XIMLUCI Solution for injection European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
S01LA04 Ranibizumab S Sensory organs → S01 Ophthalmologicals → S01L Ocular vascular disorder agents → S01LA Antineovascularisation agents
Discover more medicines within S01LA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1893898
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 1221691001
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 106747
Country: FR Base de données publique des médicaments Identifier(s): 67026689
Country: IT Agenzia del Farmaco Identifier(s): 050443011, 050443023
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1095941, 1095942
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W69269001, W69269002

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.